![Linda Rubinstein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Linda Rubinstein
Directeur Financier/CFO chez
NEKTAR THERAPEUTICS
Profil
Linda M.
Rubinstein is Chief Financial & Accounting Officer at Nektar Therapeutics since 2026.
Ms. Rubinstein is Partner at FLG Partners LLC since 2010.
Former roles include Chief Financial & Accounting Officer at Adverum Biotechnologies, Inc. from 2022 to 2025, Chief Accounting Officer at Alector, Inc. from 2022 to 2022, Chief Financial Officer at Apexigen, Inc. from 2018 to 2022, Independent Director at Biocept, Inc. from 2021 to 2023, Chief Financial & Accounting Officer at Five Prime Therapeutics, Inc. in 2018, Chief Financial Officer at ArmaGen, Inc. from 2015 to 2020, Chief Financial Officer & Executive Vice President at Emergent Travel Health, Inc. in 2014, Director at Sensor Innovations, Inc. from 2007 to 2015, Chief Financial Officer at Solexa, Inc. from 2005 to 2007, Chief Financial Officer & Senior Vice President at Ingenuity Systems, Inc., Chief Financial Officer at RenovoRx, Inc., Chief Financial Officer at iPierian, Inc., Senior Banker at Lehman Brothers, Inc., Principal at Merrill Lynch Capital Partners, Inc., and Independent Director at Biocept, Inc. Education includes undergraduate and graduate degrees from the University of California, Los Angeles.
Postes actifs de Linda Rubinstein
| Sociétés | Poste | Début |
|---|---|---|
| NEKTAR THERAPEUTICS | Directeur Financier/CFO | 15/05/2026 |
FLG Partners LLC
 FLG Partners LLC Miscellaneous Commercial ServicesCommercial Services Operates consulting and board advisory company | Corporate Officer/Principal | 01/09/2010 |
Anciens postes connus de Linda Rubinstein
| Sociétés | Poste | Fin |
|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Directeur Financier/CFO | 09/12/2025 |
| BIOCEPT, INC. | Directeur/Membre du Conseil | 13/10/2023 |
| APEXIGEN, INC. | Directeur Financier/CFO | 10/06/2022 |
| ALECTOR, INC. | Directeur Financier/CFO | 07/02/2022 |
ArmaGen, Inc.
 ArmaGen, Inc. Pharmaceuticals: MajorHealth Technology Develops neurological therapies | Directeur Financier/CFO | 01/04/2020 |
Formation de Linda Rubinstein
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
64
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Nektar Therapeutics
 Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
Biocept, Inc.
 Biocept, Inc. Medical/Nursing ServicesHealth Services Develops and performs clinical laboratory tests to detection & analysis of tumor cells and cell-free DNA from cerebrospinal fluid | Health Services |
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
Ingenuity Systems, Inc.
 Ingenuity Systems, Inc. Information Technology ServicesTechnology Services Provides information solutions for life science researchers | Technology Services |
Emergent Travel Health, Inc.
 Emergent Travel Health, Inc. Commercial Printing/FormsCommercial Services Provides vital travel health information services | Commercial Services |
Sensor Innovations, Inc.
 Sensor Innovations, Inc. BiotechnologyHealth Technology Develops and commercializes a novel, proprietary and versatile sensing technology platform | Health Technology |
ArmaGen, Inc.
ArmaGen, Inc. Pharmaceuticals: MajorHealth Technology Develops neurological therapies | Health Technology |
RenovoRx, Inc.
 RenovoRx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops therapies for the local treatment of solid tumors | Health Technology |
Merrill Lynch Capital Partners, Inc.
 Merrill Lynch Capital Partners, Inc. Investment Banks/BrokersFinance Security brokers & dealers | Finance |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solexa, Inc.
 Solexa, Inc. Pharmaceuticals: OtherHealth Technology Creates DNA cloning and analyses technologies | Health Technology |
iPierian, Inc.
 iPierian, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
FLG Partners LLC
FLG Partners LLC Miscellaneous Commercial ServicesCommercial Services Operates consulting and board advisory company | Commercial Services |
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies | Health Technology |
Alector, Inc.
 Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
Apexigen, Inc.
 Apexigen, Inc. BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancer | Health Technology |
